Chang David J.

Chief Medical OfficerCabaletta Bio, Inc. (CABA) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2025Grant(A)38K$038K
May 19, 2025Disposed to issuer(D)38K$00
May 19, 2025Grant(A)49K$049K
May 19, 2025Disposed to issuer(D)49K$00
May 19, 2025Grant(A)186K$0186K
May 19, 2025Disposed to issuer(D)186K$00
May 19, 2025Grant(A)130K$0130K
May 19, 2025Disposed to issuer(D)130K$00
May 19, 2025Grant(A)150K$0150K
May 19, 2025Disposed to issuer(D)150K$00
May 19, 2025Grant(A)135K$0135K
May 19, 2025Disposed to issuer(D)135K$00
May 19, 2025Grant(A)114K$0114K
May 19, 2025Disposed to issuer(D)114K$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-074808) within minutes of acceptance. Every field above traces to the original document. Verify it directly: